HemaCare to be acquired by Charles River Laboratories for $380m

pharmanewsdaily- December 18, 2019 0

Charles River acquisition of HemaCare : Charles River Laboratories International, an early-stage contract research organization, has agreed to acquire HemaCare for about $380 million in ... Read More